کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4216045 1281159 2011 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Embolie pulmonaire aiguë : prise en charge actuelle et perspectives
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی ریوی و تنفسی
پیش نمایش صفحه اول مقاله
Embolie pulmonaire aiguë : prise en charge actuelle et perspectives
چکیده انگلیسی
The current therapeutic approach of pulmonary embolism is mainly based on anticoagulant drugs. Low-molecular-weight heparin and fondaparinux are the two main drugs for the initial period. Unfractionated heparin remains indicated for a few patients with a contraindication to the former drugs. Outpatient treatment for low-risk patients, the role of thrombolytic treatment in patients with intermediate-risk pulmonary embolism, the indications of temporary vena cava filters and the optimal duration of anticoagulant treatment in patients with unprovoked pulmonary embolism are currently investigated in large phase III studies. Finally, several oral inhibitors of Factor IIa and Factor Xa are currently investigated in large trials.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue des Maladies Respiratoires Actualités - Volume 3, Supplement 2, March 2011, Pages S56-S60
نویسندگان
, ,